MedTrace Logo

Moletest Clinical Study in Scotland

NCT02196246 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1120

Last updated 2017-12-04

No results posted yet for this study

Summary

To evaluate an iPad based photoimage analysis system (Moletest) for improving discrimination of benign from malignant suspicious skin lesions or moles. Specifically the objective is to demonstrate that the Moletest system is able with a sufficient degree of confidence (95%) to identify lesions which are benign

Conditions

Sponsors & Collaborators

  • Digital Health & Care Institute

    collaborator OTHER

  • NHS Lanarkshire

    collaborator OTHER_GOV

  • Moletest Scotland Ltd

    lead INDUSTRY

Principal Investigators

  • Peter Freedman · Royal College of Physicians

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-27
Primary Completion
2016-10-12
Completion
2017-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02196246 on ClinicalTrials.gov